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The primary goals of this study were to investigate the potential roles of miR-200b in
regulating RMP7-induced increases in blood-tumor barrier (BTB) permeability and some
of the possible molecular mechanisms associated with this effect. Microarray analysis
revealed 34 significantly deregulated miRNAs including miR-200b in the BTB as induced
by RMP7 and 8 significantly up-regulated miRNAs in the BTB by RMP7. RMP7 induced
tight junction (TJ) opening of the BTB, thereby increasing BTB permeability. Associated
with this effect of RMP7 was a decrease in miR-200b expression within the human
cerebral microvascular endothelial cells line hCMEC/D3 (ECs) of the BTB. Overexpression
of miR-200b inhibited endothelial leakage and restored normal transendothelial electric
resistance values. A simultaneous shift in occludin and claudin-5 distributions from
insoluble to soluble fractions were observed to be significantly reduced. In addition,
overexpression of miR-200b inhibited the relocation of occludin and claudin-5 from
cellular borders into the cytoplasm as well as the production of stress fiber formation
in GECs (ECs with U87 glioma cells co-culturing) of the BTB. MiR-200b silencing
produced opposite results as that obtained from that of the miR-200b overexpression
group. Overexpression of miR-200b was also associated with a down-regulation in
RhoA and ROCKII expression, concomitant with a decrease in BTB permeability. Again,
results which were opposite to that obtained with the miR-200b silencing group. We
further found that miR-200b regulated BTB permeability by directly targeting RhoA
and ROCKII. Collectively, these results suggest that miR-200b’s contribution to the
RMP7-induced increase in BTB permeability was associated with stress fiber formation
and TJ disassembly as achieved by directly targeting RhoA and ROCKII.
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INTRODUCTION
RMP7, a synthetic bradykinin (BK) analog, is a potent and specific BK B2 receptor agonist.
RMP7 has a longer plasma half-life and less toxicity than BK and can selectively bind to B2
receptors on endothelial cells thus forming a tight junction (TJ) (Bartus et al., 1996). The
interaction of BK or RMP7 with the B2 receptor results in a rapid, but transient, increase in the
permeability of the blood-brain barrier (BBB) and blood-tumor barrier (BTB) (Inamura et al., 1994;
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Elliott et al., 1996; Matsukado et al., 1996; Bartus et al., 2000;
Emerich et al., 2000). It has been reported that intracarotid
infusion of RMP-7 is shown to increase the delivery of
carboplatin more than 2-fold and to improve survival in a rat
glioma model (Emerich et al., 1999). In line with these findings,
the results from our laboratory demonstrated that BK increased
the permeability of the BTB (Ma and Xue, 2010; Ma et al., 2012).
MicroRNAs (miRNAs) are non-coding, single-stranded, small
RNA molecules of approximately 20–22 nucleotides in length
that can inhibit gene expression at the post-transcriptional
level through nucleotide base pairings between complementary
sequences of miRNAs and the 3′ untranslated regions (3′-UTR)
(Wei and Pei, 2010;Wang et al., 2012). MiRNAs have been shown
to play important roles in embryonic development, cancer, as well
as in a variety of other physiological and pathological processes
(Alvarez-Garcia andMiska, 2005). The paucity of data onmiRNA
alterations during the process of RMP7-induced TJ opening of
the BTB and the implications for the potential use of miRNAs
as biomarkers in therapeutic approaches led us to evaluate the
differential expression of miRNAs by microarray analysis and
quantitative real-time PCR (Quantitative RT-PCR) in response
to RMP7.
The small GTPase, RhoA, and its downstream effector,
ROCKII, the major downstream effector of activated RhoA,
are known to stimulate F-actin rearrangement and regulate a
number of cellular processes, including cytoskeletal dynamics,
cell polarity, membrane transport, and gene expression (Jaffe
and Hall, 2005; Bryan et al., 2010). In addition, RhoA/ROCKII
signaling is believed to serve as an important signal molecule
which contributes to stress fiber formation as associated with
TJ disassembly and increased endothelial permeability (Wojciak-
Stothard et al., 2006; Chen et al., 2011; Han et al., 2013;
Mangialardi et al., 2013). In accord with these reported actions
of RhoA/ROCKII signaling are the results from our laboratory
which demonstrate that RhoA/ROCKII signaling was required
for a BK-induced increase in BTB permeability (Ma and Xue,
2010; Ma et al., 2012). However, the underlying mechanisms
remain unclear. Results from recent studies have revealed that
miR-133b promotes neurite outgrowth and miR-122 suppresses
hepatocellular carcinoma cell motility and invasion by targeting
RhoA (Wang et al., 2014a; Lu et al., 2015). As indicated
by gene ontology analysis, a predominant effect of miR-
200b targets involve that of a widespread, coordinated control
of actin cytoskeleton dynamics. Functional characterizations
of these miR-200b targets indicate that they constitute sub-
networks that underlie the ability of cancer cells to migrate
and invade, including the coordination of effects on Rho-ROCK
signaling, cytoskeletal remodeling, invadopodia formation and
Abbreviations: 3′-UTR, 3′-untranslated region; AGE, Advanced glycation end;
BBB, blood-brain barrier; BK, bradykinin; BTB, blood-tumor barrier; BSA,
bovine serum albumin; D-PBS, Dulbecco’s phosphate-buffered saline; DMEM,
Dulbecco’s modified Eagle’s medium; ECs, human cerebral microvascular
endothelial cells line hCMEC/D3; EDTA, ethylenediamine tetraacetic acid;
EMT, epithelial-to-mesenchimal transition; HRP, Horseradish; PAGE, SDS-
polyacrylamide gel electrophoresis; miRNAs, MicroRNAs; Quantitative RT-PCR,
Reverse Transcription and Quantitative Real Time PCR; SDS, sodium dodecyl
sulfate; TEER, transendothelial electric resistance; TJ, tight junction.
MMP activity (Bracken et al., 2014). These studies demonstrate
that miR-200b and other miRNAs could regulate the Rho-ROCK
signal pathway by directly targeting RhoA and ROCK.
The primary goals of this study were to, (1) identify critical
miRNAs associated with RMP7-induced TJ opening of the BTB
and (2) perform a comprehensive analysis of miRNA regulation
in RhoA and ROCKII expression in GECs (ECs with U87 glioma
cells co-culturing) of the BTB. To accomplish these goals, the
regulatory effects of potential miRNAs on RhoA and ROCKII
were investigated along with the potential mechanisms of RMP7-
induced TJ opening in the BTB.
MATERIALS AND METHODS
Cell Lines and Cultures
The immortalized human cerebral microvascular endothelial
cell line hCMEC/D3 (ECs) was a generous gift from Dr.
Couraud (Institut Cochin, Paris, France). The cells were
cultured on culture flasks coated with 150mg/ml of cultrex
rat collagen I (R&D Systems, Minneapolis, MN) in EBM-2
medium (Lonza,Walkersville, MD, USA, Paisley, UK) containing
1% chemically defined lipid concentrate (Life Technologies
Corporation, Paisley, UK), 5mg/ml ascorbic acid (Sigma–
Aldrich, St Louis, MO, USA) and 1 ng/ml human basic fibroblast
growth factor (bFGF, Sigma–Aldrich), supplemented with 5%
fetal bovine serum (FBS, PAA Laboratories GmbH, Pasching,
Austria). The ECs were cultured at 37◦C in a humidified
atmosphere containing 5% CO2, and cells at passages 30–40 were
used for the experiments, withmedium being refreshed every 3–4
days.
The U87 human glioblastoma cell line was obtained from the
Shanghai Institute for Biological Sciences Cell Resource Center.
The cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) with high glucose and 10% fetal bovine serum in a
humidified atmosphere of 5% CO2 at 37
◦C.
The In vitro BTB Model
To establish in vitro BTBmodels, U87 cells were seeded at 2×104
per well in six-well plates and cultured for 2 days. After the U87
cells were confluent, ECs were seeded at 2 × 105 per well in
the upper compartment of the transwell system (0.4mm pore
size; Corning, NY). ECs and U87 cells were co-cultured in the
transwell system for 4 days according to procedures previously
established within our laboratory (Ma and Xue, 2010; Ma et al.,
2012, 2014a; Zhao et al., 2015). These co-cultured endothelial
cells were referred to as glioma endothelial cells (GECs) as
compared with that of the ECs.
MiRNA Expression Profiles and MiRNA
Target Analyses
A total of 10 samples from 2 different groups were used
in this study. The 2 basic groups from which these samples
consisted of the BTB control group (ECs monolayer, with U87
glioma cells co-culturing) and the RMP7 group, with 10min
durations of RMP7 exposure. Total RNA from GECs was
collected with use of the Qiagen miRNeasy Mini kit (Qiagen
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Inc., Germantown, MD, USA) according to the manufacturer’s
instructions. MiRNA expression profiles were performed using
the TaqMan MicroRNA Assay Human Set (Applied Biosystems,
Foster, VA, USA) on the 7900HT Fast Real-Time PCR System
(Applied BIosystem, Foster City, CA, USA), according to the
manufacturer’s instructions. Raw cycle threshold (Ct) values
were calculated using SDS 2.3 and RQ manager 1.2 software
(Applied Biosystems) as achieved by applying automatic baseline
and threshold settings. RNU-44 was used as an endogenous
control. The –1Ct was calculated and heatmap analysis was
performed with hierarchical clustering. Target prediction was
performed using the open source program miRTarBase, MiRDB,
Targetscan, Miranda and Pictar (http://mirtarbase.mbc.nctu.
edu.tw/, http://www.mirdb.org/miRDB/, http://www.targetscan.
org/, http://www.microrna.org/ and http://pictar.mdc-berlin.
de/).
Drug Treatment and Experimental Groups
RMP7 (5 nmol/l Sigma–Aldrich, St Louis, MO, USA) was added
to the upper chamber (Prados et al., 2003; Packer et al., 2005).
There were seven groups in our present study (n = 5/group): the
control group (BTB group, ECs monolayer with U87 glioma cells
co-culturing) and 6 RMP7 groups consisting of RMP7 exposure
for 0, 5, 10, 15, 30, or 60min.
Measurement of Transendothelial Electric
Resistance (TEER)
The electrical resistance of GEC monolayers cultured on
transwell filters was measured using a Millicell-ERS instrument
(Millipore, Billerica, MA, USA). Electrical resistance was
expressed in units of cm2 using the surface area of the transwell
insert (Ma and Xue, 2010; Ma et al., 2012, 2014a; Zhao et al.,
2015).
Horseradish Peroxidase (HRP) Flux
Measurement
Horseradish peroxidase (HRP, Sigma-Aldrich) at 0.5µmol/l in
serum-free EBM-2 was added to the upper chamber of the
transwell system after in vitro BTB models were successfully
established. Following RMP7 administration at the times
indicated, the media from the lower chamber was collected. The
HRP flux was expressed as picomoles passed per cm2 surface area
(Ma and Xue, 2010; Ma et al., 2012, 2014a; Zhao et al., 2015).
Reverse Transcription and Quantitative
Real Time PCR (Quantitative RT-PCR)
This assay was used to detect mRNA expression levels of
miR-200b in GECs, the efficiency of miR-200b transfection and
mRNA expression levels of RhoA and ROCKII in GECs of the
BTB. MiRNAs were extracted with use of a miRNA Isolation
Kit (RNAiso for Small RNA, TaKaRa, Dalian, China) according
to the manufacturer’s instructions. Total RNAs were isolated
using Trizol reagent (Life Technologies Corporation, Carlsbad,
CA, USA) according to the manufacturer’s instructions. Reverse
transcription was performed with use of a PrimeScriptTM
RT reagent Kit (TaKaRa, Dalian, China) according to the
manufacturer’s instructions. Quantitative RT-PCR was
performed with use of a PCR kit (TaKaRa, Dalian, China).
Quantitative RT-PCR primers for mir-200b (DHM0179) and
U6 (D356-03) were purchased from TaKaRa (TaKaRa, Dalian,
China). The forward and reverse primers of each PCR set,
the sizes of PCR products, GenBank accession numbers,
oligonucleotides, and annealing temperatures are presented in
Table 1. PCR was performed for forty cycles with the following
parameters: 10 s at 95◦C, and for each cycle 5 s at 95◦C for
denaturing and 20 s at 60◦C for annealing. All quantitative
RT-PCR analyses were conducted with use of a 7500 Fast
Real-Time PCR System (Applied Biosystems). Expression levels
of miR-200b and other genes were normalized to that of the
U6 housekeeping gene and GAPDH by the delta Ct value,
respectively.
Cell Transfection
The miRNA-200b mimics (GenePharma, Shanghai, China),
miRNA-200b inhibitors (GenePharma, Shanghai, China)
and their negative control molecules were synthesized by
GenePharma. The sequence of miRNA-200bmimic and inhibitor
were as follows: UAAUACUGCCUGGUAAUGAUGAAUCAU
UACCAGGCAGUAUUAUU and UCAUCAUUACCAGGCAG
UAUUA, respectively. The sequence of their corresponding
negative control molecules were as follows: UUCUCCGAACGU
GUCACGUTTACGUGACACGUUCGGAGAATT and CAGU
ACUUUUGUGUAGUACAA, respectively. GECs at 60–80%
confluence in the upper compartment of transwell inserts were
transfected with oligonucleotides using lipofectamine 3000
reagent (Life Technologies Corporation, Carlsbad, CA, USA)
according to the manufacturer’s instructions and were added
directly to the cells to a final oligonucleotide concentration of
50 nM. After transfection for 72 h, the medium was replaced with
TABLE 1 | Oligonucleotides used for quantitative RT-PCR, their Amplicon Size, GenBank accession number, and annealing temperatures.
Gnen Sequence Amplicon size Genbank accession number Annealing Temperature
RhoA (F) 5′-TCTGTCCCAACGTGCCCATC -3′
(R) 5′-CCCAAAAGCGCCAATCCTGT -3′
149 NM_001664.2 60◦C
ROCKII (F) 5′-CTCCATTTTATGCGGATTCACTTG-3′
(R) 5′-TGATTTCTTCCACCCCATTTCTC-3′
171 NM_004850.3 60◦C
GAPDH (F)5′-AAATCCCATCACCATCTTCCAG -3′
(R) 5′-TGATGACCCTTTTGGCTCCC -3′
149 NM_002046.4 60◦C
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fresh EBM-2 medium containing 5% fetal bovine serum and the
cells were incubated for 96 h. The transfected efficacy of miRNA-
200b mimics and miRNA-200b inhibitors were analyzed by
real-time PCR. Those transfected with miRNA precursors were
divided into 5 groups: (1) controls with no miRNA precursor but
containing PBS, (2) pre-miR-con containing a pre-miR negative
control precursor, (3) pre-miR-200b containing a miR-200b
precursor, (4) anti-miR-con containing an anti-miR negative
control precursor, and (5) anti-miR-200b containing a miR-200b
inhibitor precursor.
Cell Fractionation and Western Blot
Confluent GECs were washed three times with Dulbecco’s
phosphate-buffered saline (D-PBS) containing 0.1mM
ethylenediamine tetraacetic acid (EDTA) without calcium
and magnesium. The GECs were homogenized in 1ml lysis
buffer A [2mM EDTA, 10mM ethylene glycol tetraacetic acid
(EGTA), 0.4% NaF, 20mM Tris-HCl, protease inhibitor cocktail,
1% Triton X-100, pH 7.5] at 4◦C. Samples were centrifuged
at 14,000 g for 30min, the supernatant was transferred to a
separate tube and collected as the soluble fraction (S). Buffer
A (150µl) with 1% sodium dodecyl sulfate (SDS) at 4◦C was
then added to the pellet. The pellet was disrupted with an
ultrasonic crusher. Samples were then centrifuged at 14,000
g for 30min at 4◦C as described above. The supernatant was
collected as the insoluble fraction (IS). Equal amounts of proteins
(40–50µg) were separated and processed for immunoblotting
with antibodies for claudin-5 (diluted1:250; Life Technologies
Corporation, Frederick, MD, USA), occludin (diluted 1:250;
Life Technologies Corporation, Frederick, MD, USA), RhoA
(diluted 1:300; Abcam, Cambridge, UK) and ROCK II (diluted
1:300; geneTex, Irvine, California, USA). All protein bands
were scanned using ChemiImager 5500V2.03 software. The
integrated density values (IDV) were calculated by computerized
image analysis system (Fluor Chen 2.0) and normalized with that
of GAPDH.
Immunofluorescence
U87 cells were trypsinized, then plated onto 6-well culture plates
with suitable culture medium (high-glucose DMEM, 10% fetal
bovine serum, 100 U/ml penicillin, 100µg/ml streptomycin)
containing 103 cells. When 80% of the U87 cells were confluent,
the complete culture media was aspirated and replaced with
fresh EBM-2 medium containing 5% fetal bovine serum. EC
monolayers grown on glass coverslips were placed into culture
plates and co-cultured for 4 days. The GEC monolayers grown
on glass coverslips were fixed with 4% paraformaldehyde and
permeabilized with 0.5% Triton X-100. After blocking with 2%
bovine serum albumin (BSA) in PBS, the cells were incubated
with mouse anti-occludin (diluted 1:50; Life Technologies
Corporation, Frederick, MD, USA) and rabbit anti-claudin-5
(diluted 1:50; Life Technologies Corporation, Frederick, MD,
USA) to visualize the distribution of occludin and claudin-
5, respectively. The cells were incubated with rhodamine-
labeled phalloidin (diluted 1:250; Sigma-Aldrich) to assess actin
filaments. The cells were incubated with mouse anti-RhoA
(diluted 1:150; Abcam, Cambridge, UK) and rabbit anti-ROCK
II (diluted 1:50; GeneTex, Irvine, California, USA) to analyze
their expression. The glass slides were then evaluated using
immunofluorescence microscopy (Olympus, Japan).
Plasmid Construction and Dual-Luciferase
Reporter Assay
The target genes of miR-200b were predicted with the help
of Bioinformatics software: miRTarBase, MiRDB, Targetscan,
Miranda and Pictar (http://mirtarbase.mbc.nctu.edu.tw/, http://
www.mirdb.org/miRDB/, http://www.targetscan.org/, http://
www.microrna.org/ and http://pictar.mdc-berlin.de/). Wild-type
RhoA and ROCKII 3′-UTR reporter plasmids (RhoA wt and
ROCKII wt ) and mutated-type RhoA and ROCKII 3′-UTR
reporter plasmids (RhoA mut and ROCKII mut) were cloned
to pmirGLO-promoter vector according to the miR-200b
seed sequence (GenePharma, Shanghai, China). A plasmid
carrying a non-targeting sequence was used as a negative control
(NC). HEK 293 T cells were seeded and cultured in 96-well
microtiter plates (Corning, NY) for 24 h. HEK 293 T cells were
then transfected with the pmirGLO empty vector (marked as
“Control”), co-transfected with the wild-type or mutated RhoA
and ROCKII 3′-UTR reporter plasmids or transfected with
pre-miR-200b or pre-miR-con precursors. Luciferase assays
were performed 48 h after transfection using the Dual-Luciferase
Reporter Assay System (Promega, WI, USA).
Data Analysis
Experiments were replicated a minimum of three times. Data are
presented as means ± standard deviations (SD). Comparisons
among more than two groups were performed using a one-way
analysis of variance (ANOVA) followed by Dunnett’s test for pos-
hoc comparisons. A P < 0.05 was required for results to be
considered statistically significant.
RESULTS
Effect of RMP7 on Changes in Distinct
MiRNA Expression Profiles in the BTB
MiRNA gene expression profiles were successfully obtained from
samples in each group. In total, 322 miRNAs were detected
in the TaqMan R© Array MicroRNA human card A and B
(Figure 1A and see Supplementary Material). Heat-map analysis
was performed using the -1CT value and showed that the
expression of most miRNAs appeared quite consistent across
the different samples, indicating that the overall miRNA gene
expression profiles among different individuals were consistent.
A -1CT value > 35 was established as a cut off and was then
not subjected to further analysis. Microarray analysis revealed 34
significantly deregulatedmiRNAs includingmiR-200b in the BTB
as induced by RMP7 and 8 significantly up-regulated miRNAs
in the BTB by RMP7 as compared with that observed within
the BTB control (Figure 1B). After being treated with RMP7,
the expression of miR-200b was significantly down-regulated by
3.3 ± 0.6-fold as compared with that of the BTB control group
(Figure 1B). This reduction in miR-200b expression ranked third
when considering all deceased miRNAs as determined by gene
chip.
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FIGURE 1 | Effect of RMP7 on changes in distinct miRNA expression profiles of the BTB. (A) MiRNA gene expression profiles as obtained from samples in
the BTB and RMP7 groups. (B) miRNA expression in RMP7 10min group was significantly up-regulated and down-regulated compared to BTB group.
Conserved sequences are similar or identical with those
that occur within nucleic acid sequences (such as RNA and
DNA sequences). In the case of cross species conservation, this
indicates that a particular sequence may have been maintained
by evolution, despite speciation. Conserved sequences in the 3′-
UTR of RhoA and ROCKII are CAGUAUU and ACUAUUA,
respectively. Validated target genes were analyzed using the
databases of miRTarBase, MiRDB, Miranda, TargetScan and
Pictar repositories. As based upon the results of these analyses,
binding of miRNA-200b to both RhoA and ROCKII was
observed using MiRDB, Miranda and TargetScan, while use of
miRTarBase indicated that binding of miRNA-200b was observed
only to ROCKII, and Pictar indicated an absence of miRNA-200b
binding to either RhoA or ROCKII. Moreover, miR-200b was
shown to have a putative binding site at the 3′-UTR region of
RhoA and ROCKII with a 100% conserved sequence as revealed
by TargetScan (data not shown).
RMP7 Decreased the Expression of
MiR-200b in GECs
As shown in Figure 2, RMP7 significantly induced a time
dependent decrease in miR-200b mRNA expression, with
nadir values being obtained at 10min after RMP7 treatment.
Thereafter, miR-200b expressions gradually increased and were
restored to their original basal levels.
Effect of RMP7 on Changes in HRP Flux
and TEER of the BTB
GECs from the RMP7 groups were treated with RMP7 (5 nmol/l)
for 0, 5, 10, 15, 30, or 60min. After RMP7 administration, TEER
FIGURE 2 | Relative expression of miR-200b as detected by
quantitative RT-PCR. GECs from the RMP7 groups were treated with RMP7
(5 nmol/l) for 0, 5, 10, 15, 30, or 60min. U6 RNA level was used as an internal
control. Values are means ± SD (n = 5/group). *P < 0.05 vs. the other groups;
ns, non-significant.
values were decreased by 5min, reaching their lowest values
at 15min and increased thereafter (Figure 3A). Meanwhile, we
observed that RMP7 significantly increased HRP flux in a time-
dependent manner, with peak levels observed at 15min after
RMP7 treatment (Figure 3B). These results, as obtained with
the TEER and HRP flux assays, revealed that the TJ of the BTB
was opened by RMP7; results which were consistent with our
previous findings demonstrating a BK-induced TJ opening of the
BTB (Liu et al., 2008; Ma and Xue, 2010; Ma et al., 2012).
Verification of Transfected Efficiency for
MiR-200b Mimics and Inhibitors
Quantitative RT-PCR was performed to detect the transfected
efficacy of miRNA-200b mimics and miRNA-200b inhibitors.
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FIGURE 3 | Effect of RMP7 on changes in HRP flux and TEER of BTB. (A) TEER values of GECs were expressed as  cm2. GECs from RMP7 groups were
treated with RMP7 (5 nmol/l) for 0, 5, 10, 15, 30, or 60min. Values are means ± SD (n = 5/group). *P < 0.05 vs. control group; #P < 0.05 vs. the other groups. (B)
HRP flux was calculated as pmol/cm2. GECs from the RMP7 groups were treated with RMP7 (5 nmol/l) for 0, 5, 10, 15, 30, or 60min. Values are means ± SD
(n = 5/group). *P < 0.05 vs. control group; #P < 0.05 vs. the other groups.
As shown in Figure 4, a time-dependent increase of miRNA-
200b expression in the pre-miR-200b group was observed,
with maximal miRNA-200b expression occurring at 72 h.
The expression of miR-200b in the pre-miR-200b group was
significantly up-regulated by 6.862 ± 0.725 and 6.819 ± 0.838-
fold as compared with that of the control and pre-miR-
con groups, respectively (Figure 4). Following miRNA-200b
inhibitor transfection, a time-dependent decrease of miR-200b
expression was observed, with nadir levels obtained at 72 h,
and the expression of miR-200b increasing thereafter (Figure 4).
The expression of miR-200b in the anti-miR-200b group was
significantly down-regulated by 0.210± 0.027 and 0.207± 0.027-
fold as compared with that of the control and anti-miR-con
groups, respectively (Figure 4). Maximal transfection efficacy of
the oligonucleotides both occurred at 72 h. Therefore, the time
period of 96 h after transfection was considered as the best time
for harvest and use in the subsequent experiments.
Overexpression or Silencing of MiR-200b
Significantly Changed the Integrity and
Permeability of BTB
TEER values in the pre-miR-200b group were significantly
increased as compared with the control and pre-miR-con groups;
while TEER values in the anti-miR-200b group were markedly
decreased as compared with the control and anti-miR-con
groups (Figure 5A). No statistically significant differences were
present among the control, pre-miR-con and anti-miR-con
groups (Figure 5A). HRP flux in the pre-miR-200b group was
significantly decreased as compared with the control and pre-
miR-con groups; whereas HRP flux in the anti-miR-200b group
was dramatically increased as compared with the control and
anti-miR-con groups (Figure 5B). No significant differences were
obtained among the control, pre-miR-con and anti-miR-con
groups (Figure 5B).
Overexpression or Silencing of miR-200b
significantly Changed a Shift from
Insoluble to Soluble Fractions in Occludin
and Claudin-5 Distribution
Soluble fragments (S) of occludin and claudin-5 represent
dephosphorylated forms of fragments and are susceptible to
FIGURE 4 | Transfection efficiency for miR-200b mimics and inhibitors
as detected by quantitative RT-PCR. MiR-200b mimics and inhibitors were
transfected into GECs. U6 RNA level was used as an endogenous control.
Values are means ± SD (n = 5/group). *P < 0.05 vs. control group; #P < 0.05
vs. NC group; △P < 0.05 vs. the other groups.
non-ionic detergent extraction. Insoluble fragments (IS) of
occludin and claudin-5 represent phosphorylated forms of
fragments, which combine with actin microfilaments through
zonula occludens (ZOs) and are resistant to non-ionic detergent
extraction (Li et al., 2006; Ma and Xue, 2010; Ma et al., 2012).
As shown in Figure 6, a clear shift from insoluble to soluble
fractions of occludin and claudin-5 distribution was observed
in the pre-miR-200b and anti-miR-200b groups as revealed by
Western-blot. Significant increases in the shifts of occludin and
claudin-5 distribution were observed in the pre-miR-200b group
as compared with the control and pre-miR-con groups; whereas
a markedly decreased shift of occludin and claudin-5 distribution
in the anti-miR-200b group was obtained as compared with
the control and anti-miR-con groups. No statistically significant
differences were present among the control, pre-miR-con and
anti-miR-con groups.
Effects of MiR-200b on Relocation of
Occludin and Claudin-5 and Formation of
Stress Fibers
F-actin was found to be localized mainly at the cell periphery
(Figures 7K,L,N), where occludin and claudin-5, the two major
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FIGURE 5 | Changes in BTB integrity and permeability after overexpression or silencing of miR-200b. (A) TEER values of GECs expressed as  cm2.
Values are means ± SD (n = 5/group). *P < 0.05 vs. control group; #P < 0.05 vs. pre-miR-con group; △P < 0.05 vs. anti-miR-con group;▽P < 0.05 vs.
pre-miR-200b group. (B) HRP flux was calculated as pmol/cm2. Values are means ± SD (n = 5/group). *P < 0.05 vs. control group; #P < 0.05 vs. pre-miR-con
group; △P < 0.05 vs. anti-miR-con group;▽P < 0.05 vs. pre-miR-200b group.
FIGURE 6 | IDV ratio of IS and S in occludin and claudin-5 as detected by Western blot after overexpression or silencing of miR-200b. Soluble fragments
(S) of occludin and claudin-5 represent dephosphorylated forms and are susceptible to non-ionic detergent extraction. Insoluble fragments (IS) of occludin and
claudin-5 represent phosphorylated forms, which combine with actin microfilaments through zonula occludens (ZOs) and are resistant to non-ionic detergent
extraction. Values are means ± SD (n = 5/group). *P < 0.05 vs. control group; #P < 0.05 vs. pre-miR-con group; △P < 0.05 vs. anti-miR-con group; ▽P < 0.05 vs.
pre-miR-200b group.
components of TJs, are also localized (Figures 7A,B,D,F,G,I).
Anti-miR-200b induced the formation of stress fibers within
the center of the cell (Figure 7O), which was accompanied
by a redistribution of occludin and claudin-5 from cellular
membranes to the cytoplasm and nucleus (Figures 7E,J). Pre-
miR-200b reduced the number of central stress fibers and
strongly enhanced cell localization of F-actin within the
periphery of GECs in the BTB (Figure 7M). Furthermore, pre-
miR-200b decreased the redistribution of occludin and claudin-
5 from cellular membranes to the cytoplasm and nucleus
while enhancing cellular membrane localization of occludin and
claudin-5 in GECs of the BTB (Figures 7C,H).
Effect of RMP7 on Expression of RhoA and
ROCKII in GECs of BTB
The mRNA and protein expression levels of RhoA and
ROCKII were analyzed by real-time PCR and western blotting,
respectively. As shown in Figure 8, mRNA and protein
expressions of RhoA and ROCKII were increased after
RMP7 administration. This RMP7-induced increase was time-
dependent with maximum expression occurring at 10min.
Thereafter, mRNA and protein expressions of RhoA and ROCKII
gradually returned to basal levels.
Overexpression or Silencing of MiR-200b
Regulates the Expression of RhoA and
ROCKII
As shown in Figure 9, both mRNA and protein expressions
of RhoA and ROCKII were decreased in the pre-miR-200b
group as compared with the control and pre-miR-con groups,
but increased in the anti-miR-200b group as compared with
the control and anti-miR-con groups. No statistically significant
differences were obtained among the control, pre-miR-con
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FIGURE 7 | Immunofluorescence analysis of occludin, claudin-5 and F-actin in GECs after overexpression or silencing of miR-200b. (A,B,D) Each
represents a control group, mimic negative control group, and inhibitor negative control group in occludin. (F,G,I) Each represents a control group, mimic negative
control group, and inhibitor negative control group in claudin-5. (K,L,N) Each represents a control group, mimic negative control group, and inhibitor negative control
group in F-actin. Anti-miR-200b induced formation of stress fibers in the center of the cell (O) and is accompanied by a redistribution of occludin and claudin-5 from
cellular membranes to the cytoplasm and nucleus (E,J). Pre-miR-200b reduced the number of central stress fibers and strongly enhanced cell peripheral localization
of F-actin in GECs of the BTB (M). Furthermore, pre-miR-200b decreased the redistribution of occludin and claudin-5 from cellular membranes to the cytoplasm and
nucleus and enhanced cellular membrane localization of occludin and claudin-5 in GECs of the BTB (C,H). Black arrows show the localization of peri-cellular dense
aggregates of actin filaments in GECs. Green arrows show stress fibers. Scale bars represent 20µm.
and anti-miR-con groups (Figures 9A–C). Immunofluorescence
analysis revealed that RhoA and ROCKII weremainly distributed
in the cytoplasm and nuclei of GECs in the BTB (Figures 9D,E),
with similar changes being observed in the alteration of mRNA
and protein. An inverse relationship was present between the
miR-200b and expressions of RhoA and ROCKII.
RhoA and ROCKII were Direct Targets of
MiR-200b
Bioinformatics software (http://www.targetscan.org/) available
on the public miRNA databases were used to predict a binding
site between the seed region of miR-200b and 3′-UTR of RhoA
and ROCKII. MiR-200b was shown to have a putative binding
site to the 3′-UTR region of RhoA and ROCKII with a 100%
conserved sequence. RhoA and ROCKII were predicted to harbor
one highly conservative miR-200b binding site in the 3′-UTR at
position 133–139 and 912–918, respectively. The seed for miR-
200b to RhoA and ROCKII 3′-UTR is shown in Figures 10A,C.
In order to assess whether RhoA and ROCKII were functional
targets of miR-200b, luciferase reporter plasmids containing
the wild-type 3′-UTR of RhoA and ROCKII (RhoA-3′UTR-
Wt and ROCKII-3′UTR-Wt) were constructed. As expected,
the relative luciferase activity of the RhoAwt.pre-miR-200b and
ROCKII wt.pre-miR-200b groups were significantly decreased in
comparison with that of the RhoAwt.pre-miR-con and ROCKII
wt.pre-miR-con groups (Figures 10B,D). These results suggest
that miR-200b inhibited the 3′-UTR function of RhoA and
ROCKII. To further verify whether miR-200b directly targeted
RhoA and ROCKII through the predicted binding site, luciferase
reporter plasmids containing the Mut-type 3′-UTR of RhoA
and ROCKII (RhoA-3′UTR-Mut and ROCKII-3′UTR-Mut) were
constructed. Co-transfection of miR-200b and RhoA-3′UTR-
Mut or ROCKII-3′UTR-Mut did not change luciferase activity
(Figures 10B,D). These results indicate that RhoA and ROCKII
were direct targets of miR-200b with the specific binding site
being located at the seed sequence.
DISCUSSION
The primary goals of this study were to identify the critical
miRNAs associated with RMP7-induced increases in BTB
permeability and identify some of the underlying mechanisms
related with this effect. We took advantage of gene chip
technology to detect miRNA profiles in two basic groups—
the BTB control and RMP7 treated groups. Microarray,
combined with confirmatory quantitative RT-PCR analyses
revealed a significant deregulation in miR-200b in the RMP7
group, which led to an increased expression of their target
genes, RhoA and ROCK II. MiR-200b directly targeted
RhoA and ROCK by binding to specific sites which mediate
RMP7-induced changes in actin cytoskeleton rearrangement,
TJ-associated protein redistribution and BTB permeability.
To our knowledge, this is the first report demonstrating
that miRNA is involved in an RMP7-induced increase in
BTB permeability.
Results from preclinical studies have confirmed that RMP7
not only increases BBB, but BTB permeability as well (Prados
et al., 2003). Our current in vitro results indicate that BTB
permeability to RMP7 achieved maximal levels at 15min,
and decreased thereafter. Interestingly, even with a continuous
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FIGURE 8 | Effect of RMP7 on expression of RhoA and ROCKII in GECs of the BTB. GECs from RMP7 groups were treated with RMP7 (5 nmol/l) for 0, 5, 10,
15, 30, or 60min. (A) Relative mRNA expressions of RhoA and ROCKII as determined by quantitative RT-PCR. GAPDH RNA levels were used as an endogenous
control. Values are means ± SD (n = 5/group). *P < 0.05 vs. control group; #P < 0.05 vs. RMP7 0min group;△P < 0.05 vs. RMP7 15min. (B,C) Protein expressions
of RhoA and ROCKII as assessed with Western blot. Values are means ± SD (n = 5/group).*P < 0.05 vs. control group; #P<0.05 vs. RMP7 0min group;△P < 0.05
vs. RMP7 15min.
infusion of RMP7, spontaneous barrier restoration was shown to
occur within 10–20min (Bartus et al., 2000; Kraemer et al., 2002);
and a rapid, but reversible, and relatively selective permeability of
the BTB to RMP7 has also been reported (Packer et al., 2005). As
RMP7 has a longer plasma half-life when compared with BK, an
exact explanation for the limited duration of BTB permeability to
RMP7 is not readily apparent. One possibility is the potential for
an auto-regulated internalization of B2 receptors in cells (Pizard
et al., 1999).
Microarrays have made rapid progress as a high-throughput
screening and high-performance technology. There are miRNAs,
specifically miR-181a and miR-34c, that have been reported
to be associated with TJ disassembly in the BTB, but not in
the BBB (Ma et al., 2014b; Zhao et al., 2015). The miR-34c
regulated permeability of the BTB has been shown to result
from MAZ-mediated expression changes of ZO-1, occludin and
claudin-5 (Zhao et al., 2015). While the miR-181a regulated BTB
permeability involves targeting of the Krüppel-like factor 6 (Ma
et al., 2014b). These miRNAs expression changes are believed
to be associated with deregulation of the target genes which
contribute to TJ disassembly and increases in BTB permeability.
In our study, use of gene chip technology failed to detect
expression changes of miR-181a and miR-34c in GECs of the
BTB by RMP7. These results suggest that miR-181a and miR-34c
are not involved in mediating RMP7-induced increases in BTB
permeability.
The miR-200 family of miRNAs, which includes miR-200c
and miR-141 on chromosome 12 and miR-200a/b and miR-429
on chromosome 1, have been extensively studied as related to
the epithelial-to-mesenchimal transition (EMT) of cancer cells.
The miR-200 family was recently identified as a suppressor
of EMT (Park et al., 2008). MiR-200b is down-regulated in
glioma tissues and this down-regulation is correlated with a
poor prognosis in gliomas (Peng et al., 2013a; Liu et al., 2014).
A change (loss or gain) in the miR-200 family of miRNAs is
associated with cancer invasion (Magenta et al., 2011). However,
little is known about the interrelationships between miR-200s
and properties of the endothelium.MiR-200s have been shown to
promote endothelial cell apoptosis and senescence and inhibited
the capacity for the endothelium to form tumor angiogenesis
(Choi et al., 2011; McArthur et al., 2011; Gill et al., 2012; Pecot
et al., 2013). These studies suggest that miR-200b might regulate
certain functions of endothelial cells. In the present study, we
found that RMP7-induced a decrease in miR-200b expression
within GECs of the BTB. Similarly, advanced glycation end
(AGE) induced down-regulation of miR-200b in HUVEC (Wu
et al., 2014) and a down-regulation of miR-200b was observed
in the retina in a diabetic rat model (McArthur et al., 2011).
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FIGURE 9 | Alteration of RhoA and ROCKII in GECs of the BTB after overexpression or silencing of miR-200b. (A) Relative mRNA expressions of RhoA and
ROCKII as determined by quantitative RT-PCR. GAPDH RNA levels were used as an endogenous control. Values are means ± SD (n = 5/group). *P < 0.05 vs. control
(Continued)
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FIGURE 9 | Continued
group; #P < 0.05 vs. pre-miR-con group; △P < 0.05 vs. anti-miR-con group;▽P < 0.05 vs. pre-miR-200b group. (B,C) Protein expressions of RhoA and ROCKII as
assessed with Western blot. Values are means ± SD (n = 5/group). *P < 0.05 vs. control group; #P < 0.05 vs. pre-miR-con group; △P < 0.05 vs. anti-miR-con
group;▽P < 0.05 vs. pre-miR-200b group. (D,E) Distribution and expression of RhoA and ROCKII as detected with immunofluorescence assay. RhoA (green) and
ROCKII (green) were, respectively, labeled with fluorescent secondary antibody and nuclei (blue) were labeled with DAPI. Scale bars represent 20µm.
FIGURE 10 | MiR-200b inhibits the expression of RhoA and ROCKII by targeting their 3′-UTR. (A,B) Putative binding sites of RhoA 3′-UTR and ROCKII
3′-UTR as matching with the seed region of miR-200b were predicted with the help of TargetScan6.2. (C,D) Relative luciferase activity as expressed with firefly/renilla
luciferase activity. Values are means ± SD (n = 5/group). (C,D) *P < 0.05 vs. control group; #P < 0.05 vs. RhoA wt.pre-miRcon group; △P < 0.05 vs. ROCKII
wt.pre-miR-200b con.
In addition, miR-200b expression was depleted within arsenic-
transformed human bronchial epithelial cells showing highly
migratory and invasive characteristics (Wang et al., 2014b).
When collating these findings with our current results it appears
that low expressions of miRNA-200b play a key role in a number
of physiological and pathological processes.
Our current data also demonstrate that overexpression of
miR-200b could inhibit endothelial leakage and restore normal
TEER values in the BTB. Consistent with our results, Wu et al
found that miR-200b and miR-200c mimics also inhibited AGE-
induced increases in HUVEC permeability (Wu et al., 2014).
Moreover, miR-200b mimics prevent glucose-induced increases
in permeability and angiogenesis within the retina of diabetic rats
(McArthur et al., 2011). Taken together, these results suggest that
miR-200b significantly changes the integrity and permeability of
the BTB or endothelium.
MiRNAs are small endogenous RNAs that pair with sites in
mRNAs to direct post-transcriptional repression. Many sites that
have been identified to match the miRNA seed (nucleotides 2–
7), particularly those in the 3′-UTR, are preferentially conserved
(Friedman et al., 2009). Moreover, the seed pairing site in
the 3′-UTR target is often conserved across multiple species
(Wang and El Naqa, 2008). MiRNAs can inhibit target gene
expression at the post-transcriptional level, which can then
play an important role in a wide array of biological processes
including embryonic development, cell stress responses and
oncogenesis (Keene, 2007; Chang et al., 2013a). Here we provide
evidence demonstrating that miR-200b simultaneously regulated
the expression of RhoA and ROCKII which results in F-
actin rearrangement, relocalization of occludin and claudin-5,
TJ opening and increased BTB permeability. Similar results
were observed for miR-200b, in that it was also shown to
simultaneously regulate ROCKII and SUZ12 gene expression at
the post-transcriptional level (Peng et al., 2013b), where ROCKII
can participate in the regulation of cytoskeletal signaling events.
Recent findings have demonstrated miR-200b results in F-actin
rearrangement by directly targeting PKCα (Wang et al., 2014b). It
has also been reported that miRNA-200b could promote cell cycle
and actin cytoskeletal rearrangement by directly targeting RND3,
which was considered to be a natural endogenous antagonist
of RhoA (Xia et al., 2010). Accordingly, these studies lend
credence to the possibility that miRNA-200b was closely related
to molecular events involved with cytoskeletal rearrangement.
Our results demonstrate that miR-200b directly binds to
RhoA and ROCKII 3′-UTR at positions 133–139 and 912–
918, respectively. AGE-induced miR-200b and miR-200c down-
regulation leads to an increase in the expression of their target
genes, RhoA and ROCK II in HUVEC, respectively. Moreover,
findings demonstrating that the seed region of miR-200b binds
to the RhoA 3′-UTR position are consistent with our findings
(Peng et al., 2013b). The miR-200b/c 429 cluster is considered to
have the same seed region that binds to the target gene mRNA.
The report that the seed region of miR-200c binds to the same
RhoA 3′-UTR position in the process of trabecular meshwork cell
contraction regulation, is also consistent with our findings (Luna
et al., 2012). The seed regions of miR-200b and miR-200c that
bind to the RhoA 3′-UTR position in the process of suppressing
hepatocellular carcinoma metastasis are also in accordance with
our findings, but the seed regions of miR-200b and miR-200c
that bind to the ROCKII 3′-UTR position in above-mentioned
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process were at position 1006-1013, which is inconsistent with
our results (Wong et al., 2015). These variations in binding
sites to ROCKII may be due to different conservative features
located in sites 912-918 and 1006-1013. In addition, it has been
demonstrated that MicroRNA-155 contributed to epithelial cell
plasticity by targeting RhoA (Kong et al., 2008); and, RhoA had
also been confirmed to be a direct target gene for miR-31 during
OSCC tumorigenesis (Chang et al., 2013b). The data indicating a
discrepancy in the miRNA regulation of RhoA are likely due to
differences in treatments factors and/or different protocols.
CONCLUSION
Our results suggest that RMP7 induced miR-200b down-
regulation as revealed by microarray and quantitative RT-PCR.
MiR-200b directly targeted RhoA and ROCKII, initiating a
signaling cascade that resulted in changes of RhoA and ROCKII
gene expression, stress fiber formation, TJ protein disassembly
and an increase in BTB permeability. The exact mechanism(s)
through which RMP7 repressed miR-200b expression as well as
an assessment of these effects in in vivo models remains to be
determined in future studies.
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